Recent insights into platinum drug resistance in cancer

This publication has 74 references indexed in Scilit:

• In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473
  British Journal of Cancer, 1998
• DNA interactions of bifunctional dinuclear platinum(II) antitumor agents.
  European Journal of Biochemistry, 1997
• Chemical and Biological Studies on a Series of Novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-Diaminocyclohexane)platinum(IV) Carboxylate Complexes
  Journal of Medicinal Chemistry, 1997
• Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer
  Annals of Oncology, 1996
• Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel
  Biochemical Pharmacology, 1996
• Synthesis, characterization, and antitumor activity of a series of novel cisplatin analogs with cis-1,4-diaminocyclohexane as nonleaving amine group
  Journal of Inorganic Biochemistry, 1996
• Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
  Annals of Oncology, 1996
• A Trial of Lobaplatin (D-19466) in Platinum-Resistant Ovarian Cancer
  Gynecologic Oncology, 1995
• Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer
  British Journal of Cancer, 1995
• The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes
  Pharmacology & Therapeutics, 1987